The Nonpharmacological Methods in Reducing the Pain Caused by Orogastric Tube Insertion in Preterm Infants
The Effect of Expressed Breast Milk, Swaddling and Facilitated Tucking Methods in Reducing the Pain Caused by Orogastric Tube Insertion in Preterm Infants: A Randomized, Controlled Trial
1 other identifier
interventional
187
1 country
1
Brief Summary
According to the World Health Organization, preterm birth (from 20 to 37 gestation week) is a significant global health problem, as preterm infants represent an estimated 15 million infants per year worldwide. One of the important problems experienced by the preterm infants, leaving their intrauterine environment earlier than normal, while receiving special treatment and care in Neonatal Intensive Care Unit is the painful procedures. Exposure to pain may change preterm infants' brain structure and organization as well as impair brain development through oxygen desaturation, leading to generation of free radicals that can damage fast-growing tissues. For this reason, preterm infants need to be supported and protected more in pain procedures. Orogastric Tube (OGT) is a feeding method that is used to support the nutrition of preterms that cannot be fed orally and causes OGT insertion pain. Although non-pharmacological methods are effective in reducing the pain caused by OGT insertion in preterms, a limited number of studies have been found. There was no study using combined nonpharmacological methods to reduce OGT insertion pain.To evaluate the efficacy of the use of expressed breast milk, swaddling and facilitated tucking methods alone and combination in reducing the pain caused by OGT insertion in preterms. Randomized controlled trial. Three level III neonatal intensive care units in Turkey. Preterm infants born 32-34 weeks of gestation were randomly assigned to six groups: routine care group (n=33), swaddling group (n=30), facilitated tucking (n=32), expressed breast milk (n=31), swaddling+expressed breast milk group (n=30), and facilitated tucking+expressed breast milk group (n=31). OGT insertion included four phases: baseline (the last 1 min of the 30 min without stimuli), OGT insertion, recovery (1 min after OGT insertion), recovery (2 min after OGT insertion). Four phases of OGT insertion procedures were videotaped. Premature infant pain profile (PIPP) score, heart rate, and oxygen saturation were assessed by two independent evaluators who were blinded to the purpose of the study. Data were analyzed by analysis of variance for the multiple repeated measurements, bonferroni, Generalised Estimating Equation logistic regression. 187 preterm infants completed the protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Jun 2017
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2019
CompletedFirst Submitted
Initial submission to the registry
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
July 5, 2019
CompletedJuly 5, 2019
July 1, 2019
1.6 years
July 1, 2019
July 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Premature Infant Pain Profile (PIPP)
The Premature Infant Pain Profile (PIPP) scale was used for the pain assessment. The primary outcome was the pain score assessed with PIPP scale, a validated and widely used tool to measure procedural pain in preterm infants; It measures pain according to two contextual indicators (gestational age and behavioral state), two physiological indicators (heart rate and oxygen saturation), and three behavioral indicators (brow bulge, eye squeeze, and nasolabial furrow). PIPP scores ≥ 6 are suggested to indicate at least mild pain, and scores ≥ 12 are suggested to indicate moderate-to-severe pain.
1 year
Secondary Outcomes (3)
Heart Rate
1 year
Oxygen Saturation
1 year
Measurement of incidence of adverse events
1 year
Study Arms (6)
The routine care group
NO INTERVENTIONIn the routine care group, while a neonatal nurse performed the OGT insertion procedure, physiological measurements of the highest value of heart rate and the lowest value of oxygen saturation were recorded by one researcher (the first author) 1 min before the procedure, during the process and after the process in 1st and 2nd minutes acquired for each infant in the unit with an individual monitor.
The swaddling group
EXPERIMENTALIn this group, preterm infants were given swaddling method.
The expressed breast milk group
EXPERIMENTALIn this group, preterm infants were given expressed breast milk method.
The facilitated tucking group
EXPERIMENTALIn this group, preterm infants were given facilitated tucking method.
The swaddling and expressed breast milk group
EXPERIMENTALIn this group, preterm infants were given combined swaddling and expressed breast milk method.
The facilitated tucking and expressed breast milk group
EXPERIMENTALIn this group, preterm infants were given combined facilitated tucking and expressed breast milk method.
Interventions
The newborns were placed in a supine position on a 90 cm2 soft fabric for swaddling procedure. The upper side of the bandage was aligned with the shoulder of the newborn. Newborns' arms were put in a flexion position. The top of the body was completely covered with a bandage. The infant's head can move freely. The swaddling procedure took about one minute. In the study, swaddling process was applied 10 minutes before the painful procedure. The swaddled newborns remained in the swaddling during the procedure and for 5 minutes after the procedure.
In terms of the reliability of the study results, nothing was orally given to the preterm infant at least 30 minutes before the procedure. As recommended in the studies, 2 ml oral breast milk was given to preterm infants before the procedure. In the study, breast milk was given slowly to the upper part of the tongue of each preterm infant from his/her own mother as a single dose before OGT insertion. As a result, preterm was ensured to take all of 2 ml breast milk by reducing the aspiration risk of breastmilk. The breast milk was given without touching the tip of the injector to the newborn's mouth. The preterm infants were not allowed to suck the tip of the injector.
Facilitated tucking was given in supine position by holding the arm and legs of the preterm infant to the body by the researcher. In line with the literature, facilitated tucking was initiated 3 minutes before OGT insertion in order for the newborn to feel the fetal position and to cope with the painful procedure. The preterm was kept in fetal position during the procedure and for 5 minutes after the procedure.
Swaddling procedure was conducted by the researcher to the preterm infant 10 minutes before the OGT insertion procedure. 2 ml breast milk was administered by the researcher to preterm using a sterile injector as a single dose for 2 minutes before OGT insertion procedure. The preterm was remained in swaddling during the OGT insertion procedure and for 5 minutes after the process.
Facilitated tucking method was applied right after giving 2 ml breast milk by the researcher to the preterm 3 minutes before OGT insertion procedure. Preterm newborn remained in facilitated tucking during the procedure and for 5 minutes after the procedure.
Eligibility Criteria
You may qualify if:
- gestational age (GA) between 32 and 34 weeks at delivery
- postnatal age between 3 and 28 days
- being fed with OGT
- not scheduled to receive sedatives, muscle relaxants, or analgesic drugs 24 h before a study session
- having spontaneous breathing
- having breast milk. In this study, GA was defined as the time (in weeks) from the first day of the last menstrual period to date of birth.
You may not qualify if:
- history of surgery
- congenital or known genetic anomalies
- disorders affecting brain circulation or cardiovascular system
- severe medical conditions requiring treatment such as sedatives, muscle relaxants, anti-epileptic, or analgesic drugs
- in the condition of fasting
- mother with a history of substance-abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akdeniz University
Antalya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessment of the videos was blinded. PIPP score was measured by two specialist pain doctors who were blinded to the study purpose, and to the study group allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Asistant
Study Record Dates
First Submitted
July 1, 2019
First Posted
July 5, 2019
Study Start
June 15, 2017
Primary Completion
January 2, 2019
Study Completion
January 2, 2019
Last Updated
July 5, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share
The data sharing plans for the current study are unknown and will be made available at a later date